ABLATOR Ablation Observational Registry

NCT02344173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2035

Last updated 2019-06-05

Study results available
· View outcomes & findings →

Summary

The purpose of this registry is to assess the performance and clinical effectiveness of a combination of SJM mapping and ablation products in the treatment of subjects with atrial fibrillation (AF).

Conditions

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-08-18
Completion
2017-08-18

Countries

  • Austria
  • Belgium
  • Canada
  • China
  • Czechia
  • France
  • Germany
  • India
  • Italy
  • Netherlands
  • Portugal
  • Saudi Arabia
  • South Korea
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02344173 on ClinicalTrials.gov